autologous adoptive cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for autologous adoptive cell therapy, covering 2021-02-11 to 2021-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients [Phase 2]